Research Article
Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19
Table 3
Comparison of lymphocyte subsets and cytokines between two-week postrecovery patients and HCs.
| | Groups | Lymphocyte subsets (per/μL) | Groups | Cytokines (pg/mL) | | RP () | HCs () | | | RP () | HCs () | | |
| | Total lymphocyte | | | 4.85 | <0.01 | IL-2 | 0.31 (0.14, 0.80) | 0.14 (0, 0.14) | -4.27 | <0.01 | | CD3+ T cell | | | 3.80 | <0.01 | IL-4 | 1.27 (0.70, 2.56) | 0.61 (0.33, 0.70) | -5.09 | <0.01 | | CD3+CD4+ T cell | | | 3.07 | <0.01 | IL-6 | 2.98 (2.11, 4.47) | 1.36 (0.97, 1.94) | -5.23 | <0.01 | | CD3+CD8+ T cell | | | 5.92 | <0.01 | IL-10 | 2.01 (1.52, 2.47) | 1.18 (0.90, 1.38) | -5.35 | <0.01 | | CD19+ B cell | | | 3.14 | <0.01 | TNF-α | 0.92 (0.67, 3.00) | 0.43 (0.09, 0.64) | -6.25 | <0.01 | | CD56+ NK cell | 166 (83, 257) | 271 (174, 491) | -2.80 | <0.01 | INF-γ | 0.70 (0.34, 1.05) | 0.13 (0.00, 0.34) | -5.00 | <0.01 | | CD4+/CD8+ | 1.55 (1.09, 2.03) | | -1.54 | 0.12 | IL-17 | | | -5.58 | <0.01 |
|
|
RP: two-week postrecovery patients; HCs: healthy controls.
|
